Search - tctmd.com

Displaying 21 - 40 of 623

Sort: Relevancy | Date

Presentation TCT 2025

TCT 882: Impact of Different Leaflet and Stent Materials on Bileaflet Bioprosthetic Mitral Valve Performance

Presenter: Joseph Chibuike Nwokeafor

October 26, 2025

Presentation TCT 2025

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

Presenter: Khin May Thaw

October 25, 2025

Presentation TCT 2025

TCT 1103: Transcatheter vs. Surgical Replacement of Degenerated Bioprosthetic Aortic Valve Over Time: Findings from a Meta-Analysis of Propensity-Score-Matched Studies

Presenter: Mohammad Javad Namazi

October 25, 2025

Presentation TCT 2025

TCT 229: Association Between Early Bioprosthetic Valve Dysfunction and Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement

Presenter: Dhaval Kolte

October 25, 2025

Presentation TCT 2025

TCT 1302: LAVA-ECMO Supported ViV TAVR and PVL Closure in Aortic Bioprosthetic Valve Dehiscence

Presenter: Hon Yeung Ko

October 25, 2025

Presentation TCT 2025

TCT 5: A Novel Nanomaterial Surface Coating for Bioactive Drug Functionalisation of Bioprosthetic Heart Valves

Presenter: Richard Tan

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

Presentation NY Valves 2025

Novel Management of TAVR Endocarditis: Antibiotic Releasing TAVR Valve

Presenter: Alexander Lauten

June 27, 2025

Presentation NY Valves 2025

Case Resolution: Infective Endocarditis Treated with TAVR

Presenter: Mahesh V. Madhavan

June 27, 2025

Presentation NY Valves 2025

Infective Endocarditis in Patients Undergoing TAVR -Incidence, Outcome, and Recommendations for Prevention

Presenter: Bernard Prendergast

June 27, 2025

Presentation NY Valves 2025

Case Presentation: Infective Endocarditis Treated with TAVR

Presenter: Mahesh V. Madhavan

June 27, 2025

Presentation NY Valves 2025

Percutaneous Mechanical Aspiration for Right-Sided IE: Insight From CLEAR IE Registry and a Step-By-Step Guide on How to Perform

Presenter: Abdallah El Sabbagh

June 27, 2025

Presentation NY Valves 2025

Cardiovascular Imaging in Infective Endocarditis. A Multimodality Approach

Presenter: David Messika-Zeitoun

June 27, 2025

Presentation NY Valves 2025

Recent Insights Into Native Valve Infective Endocarditis: Epidemiology, Microbiology, and Outcome

Presenter: Evin Yucel

June 27, 2025

Presentation NY Valves 2025

Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture

Presenter: Adnan K. Chhatriwalla

June 27, 2025

Presentation NY Valves 2025

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Presenter: Thiago Abizaid

June 26, 2025

Presentation NY Valves 2025

Implant Considerations for TAV-in-TAV: Why Is It Different?

Presenter: Giuseppe Tarantini

June 26, 2025

Advertisement

TCT 882: Impact of Different Leaflet and Stent Materials on Bileaflet Bioprosthetic Mitral Valve Performance

TCT 1531: Transfemoral Tricuspid Valve-in-Valve (ViV) Procedure in a High-Risk Patient With Bioprosthetic Valve Failure and Prior Infective Endocarditis

TCT 1103: Transcatheter vs. Surgical Replacement of Degenerated Bioprosthetic Aortic Valve Over Time: Findings from a Meta-Analysis of Propensity-Score-Matched Studies

TCT 229: Association Between Early Bioprosthetic Valve Dysfunction and Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement

TCT 1302: LAVA-ECMO Supported ViV TAVR and PVL Closure in Aortic Bioprosthetic Valve Dehiscence

TCT 5: A Novel Nanomaterial Surface Coating for Bioactive Drug Functionalisation of Bioprosthetic Heart Valves

What’s Going to Be Hot at TCT 2025

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

FDA Expands Evolut Indications to Include Redo TAVI

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Novel Management of TAVR Endocarditis: Antibiotic Releasing TAVR Valve

Case Resolution: Infective Endocarditis Treated with TAVR

Infective Endocarditis in Patients Undergoing TAVR -Incidence, Outcome, and Recommendations for Prevention

Case Presentation: Infective Endocarditis Treated with TAVR

Percutaneous Mechanical Aspiration for Right-Sided IE: Insight From CLEAR IE Registry and a Step-By-Step Guide on How to Perform

Cardiovascular Imaging in Infective Endocarditis. A Multimodality Approach

Recent Insights Into Native Valve Infective Endocarditis: Epidemiology, Microbiology, and Outcome

Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Implant Considerations for TAV-in-TAV: Why Is It Different?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content